Sponsor pipeline

Acerand Therapeutics (Hong Kong) Limited clinical trial pipeline

Get alerts when Acerand Therapeutics (Hong Kong) Limited's trials change

1 active trials 1 recruiting 1 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-05
Primary completion pushed: 2028-03-01 → 2028-12-31
Enrollment increased: 67 → 88 participants
Completion pushed: 2028-08-01 → 2028-12-31
NCT06801236 Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate… · Phase 1

Active trials by phase

Phase 1
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT06801236 Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate… Prostate Cancer (Adenocarcinoma) Recruiting 2026-08-04

Disease areas by active trials

Prostate Cancer (1)

Get alerts when Acerand Therapeutics (Hong Kong) Limited's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free